Mitochondrial turnover and homeostasis in ageing and neurodegeneration.
ageing
energy homeostasis
human disease
mitochondria
mitochondrial turnover
mitophagy
necrosis
neurodegeneration
neurons
Journal
FEBS letters
ISSN: 1873-3468
Titre abrégé: FEBS Lett
Pays: England
ID NLM: 0155157
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
received:
12
03
2020
revised:
09
04
2020
accepted:
23
04
2020
pubmed:
1
5
2020
medline:
12
5
2021
entrez:
1
5
2020
Statut:
ppublish
Résumé
Ageing is driven by the inexorable and stochastic accumulation of damage in biomolecules vital for proper cellular function. Although this process is fundamentally haphazard and uncontrollable, genetic and extrinsic factors influence senescent decline and ageing. Numerous gene mutations and treatments have been shown to extend the lifespan of organisms ranging from the unicellular Saccharomyces cerevisiae to primates. Most such interventions ultimately interface with cellular stress response mechanisms, suggesting that longevity is intimately related to the ability of the organism to counter both intrinsic stress and extrinsic stress. Mitochondria, the main energy hub of the cell, are highly dynamic organelles, playing essential roles in cell physiology. Mitochondrial function impinges on several signalling pathways modulating cellular metabolism, survival and healthspan. Maintenance of mitochondrial function and energy homeostasis requires both generation of new healthy mitochondria and elimination of the dysfunctional ones. Here, we survey the mechanisms regulating mitochondrial number in cells, with particular emphasis on neurons. We, further, discuss recent findings implicating perturbation of mitochondrial homeostasis in cellular senescence and organismal ageing as well as in age-associated neurodegenerative diseases.
Identifiants
pubmed: 32350855
doi: 10.1002/1873-3468.13802
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2370-2379Informations de copyright
© 2020 Federation of European Biochemical Societies.
Références
Kenyon CJ (2010) The genetics of ageing. Nature 464, 504-512.
Hofer SM, Berg S and Era P (2003) Evaluating the interdependence of aging-related changes in visual and auditory acuity, balance, and cognitive functioning. Psychol Aging 18, 285-305.
Sun N, Youle RJ and Finkel T (2016) The mitochondrial basis of aging. Mol Cell 61, 654-666.
Apfeld J and Kenyon C (1998) Cell nonautonomy of C. elegans daf-2 function in the regulation of diapause and life span. Cell 95, 199-210.
Fontana L, Partridge L and Longo VD (2010) Extending healthy life span-from yeast to humans. Science 328, 321-326.
Selman C, Lingard S, Choudhury AI, Batterham RL, Claret M, Clements M, Ramadani F, Okkenhaug K, Schuster E, Blanc E et al. (2008) Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice. FASEB J. 22, 807-818.
Clancy DJ, Gems D, Harshman LG, Oldham S, Stocker H, Hafen E, Leevers SJ and Partridge L (2001) Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein. Science 292, 104-106.
Slack C, Giannakou ME, Foley A, Goss M and Partridge L (2011) dFOXO-independent effects of reduced insulin-like signaling in Drosophila. Aging Cell 10, 735-748.
Tatar M, Kopelman A, Epstein D, Tu MP, Yin CM and Garofalo RS (2001) A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function. Science 292, 107-110.
Bluher M, Kahn BB and Kahn CR (2003) Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 299, 572-574.
Flurkey K, Papaconstantinou J, Miller RA and Harrison DE (2001) Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proc Natl Acad Sci USA 98, 6736-6741.
Holzenberger M, Dupont J, Ducos B, Leneuve P, Geloen A, Even PC, Cervera P and Le Bouc Y (2003) IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 421, 182-187.
Pawlikowska L, Hu D, Huntsman S, Sung A, Chu C, Chen J, Joyner AH, Schork NJ, Hsueh WC, Reiner AP et al. (2009) Association of common genetic variation in the insulin/IGF1 signaling pathway with human longevity. Aging Cell 8, 460-472.
Suh Y, Atzmon G, Cho MO, Hwang D, Liu B, Leahy DJ, Barzilai N and Cohen P (2008) Functionally significant insulin-like growth factor I receptor mutations in centenarians. Proc Natl Acad Sci USA 105, 3438-3442.
Hay N and Sonenberg N (2004) Upstream and downstream of mTOR. Genes Dev 18, 1926-1945.
Liu GY and Sabatini DM (2020) mTOR at the nexus of nutrition, growth, ageing and disease. Nat Rev Mol Cell Biol 21, 183-203.
Herzig S and Shaw RJ (2018) AMPK: guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol 19, 121-135.
Waterson MJ and Horvath TL (2015) Neuronal regulation of energy homeostasis: beyond the hypothalamus and feeding. Cell Metab 22, 962-970.
Cone RD (2005) Anatomy and regulation of the central melanocortin system. Nat Neurosci 8, 571-578.
Nasrallah CM and Horvath TL (2014) Mitochondrial dynamics in the central regulation of metabolism. Nat Rev Endocrinol 10, 650-658.
Rizzuto R, De Stefani D, Raffaello A and Mammucari C (2012) Mitochondria as sensors and regulators of calcium signalling. Nat Rev Mol Cell Biol 13, 566-578.
Barnhart EL (2016) Mechanics of mitochondrial motility in neurons. Curr Opin Cell Biol 38, 90-99.
Buhlman L, Damiano M, Bertolin G, Ferrando-Miguel R, Lombes A, Brice A and Corti O (2014) Functional interplay between Parkin and Drp1 in mitochondrial fission and clearance. Biochem Biophys Acta 1843, 2012-2026.
Twig G, Elorza A, Molina AJ, Mohamed H, Wikstrom JD, Walzer G, Stiles L, Haigh SE, Katz S, Las G et al. (2008) Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J 27, 433-446.
Burman JL, Pickles S, Wang C, Sekine S, Vargas JNS, Zhang Z, Youle AM, Nezich CL, Wu X, Hammer JA et al. (2017) Mitochondrial fission facilitates the selective mitophagy of protein aggregates. J Cell Biol 216, 3231-3247.
Liesa M and Shirihai OS (2013) Mitochondrial dynamics in the regulation of nutrient utilization and energy expenditure. Cell Metab 17, 491-506.
Lopez-Otin C, Blasco MA, Partridge L, Serrano M and Kroemer G (2013) The hallmarks of aging. Cell 153, 1194-1217.
Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, Cline GW and Shulman GI (2003) Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300, 1140-1142.
Short KR, Bigelow ML, Kahl J, Singh R, Coenen-Schimke J, Raghavakaimal S and Nair KS (2005) Decline in skeletal muscle mitochondrial function with aging in humans. Proc Natl Acad Sci USA 102, 5618-5623.
Austin S and St-Pierre J (2012) PGC1alpha and mitochondrial metabolism-emerging concepts and relevance in ageing and neurodegenerative disorders. J Cell Sci 125, 4963-4971.
Suliman HB and Piantadosi CA (2016) Mitochondrial quality control as a therapeutic target. Pharmacol Rev 68, 20-48.
Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, Mootha V, Troy A, Cinti S, Lowell B, Scarpulla RC et al. (1999) Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98, 115-124.
Ekstrand MI, Terzioglu M, Galter D, Zhu S, Hofstetter C, Lindqvist E, Thams S, Bergstrand A, Hansson FS, Trifunovic A et al. (2007) Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons. Proc Natl Acad Sci USA 104, 1325-1330.
de Rijk MC, Breteler MM, Graveland GA, Ott A, Grobbee DE, van der Meche FG and Hofman A (1995) Prevalence of Parkinson's disease in the elderly: the Rotterdam Study. Neurology 45, 2143-2146.
Lang AE and Lozano AM (1998) Parkinson's disease. Second of two parts. New Engl J Med 339, 1130-1143.
Lang AE and Lozano AM (1998) Parkinson's disease. First of two parts. New Engl J Med 339, 1044-1053.
Galter D, Pernold K, Yoshitake T, Lindqvist E, Hoffer B, Kehr J, Larsson NG and Olson L (2010) MitoPark mice mirror the slow progression of key symptoms and L-DOPA response in Parkinson's disease. Genes Brain Behav 9, 173-181.
Kim J, Moody JP, Edgerly CK, Bordiuk OL, Cormier K, Smith K, Beal MF and Ferrante RJ (2010) Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease. Hum Mol Genet 19, 3919-3935.
Cui L, Jeong H, Borovecki F, Parkhurst CN, Tanese N and Krainc D (2006) Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 127, 59-69.
Murphy MP and Hartley RC (2018) Mitochondria as a therapeutic target for common pathologies. Nat Rev Drug Discovery 17, 865-886.
Smith RA, Hartley RC, Cocheme HM and Murphy MP (2012) Mitochondrial pharmacology. Trends Pharmacol Sci 33, 341-352.
Johri A and Beal MF (2012) Mitochondrial dysfunction in neurodegenerative diseases. J Pharmacol Exp Ther 342, 619-630.
Youle RJ and Narendra DP (2011) Mechanisms of mitophagy. Nat Rev Mol Cell Biol 12, 9-14.
Yamano K and Youle RJ (2013) PINK1 is degraded through the N-end rule pathway. Autophagy 9, 1758-1769.
Gegg ME, Cooper JM, Chau KY, Rojo M, Schapira AH and Taanman JW (2010) Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy. Hum Mol Genet 19, 4861-4870.
Geisler S, Holmstrom KM, Skujat D, Fiesel FC, Rothfuss OC, Kahle PJ and Springer W (2010) PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol 12, 119-131.
Shin JH, Ko HS, Kang H, Lee Y, Lee YI, Pletinkova O, Troconso JC, Dawson VL and Dawson TM (2011) PARIS (ZNF746) repression of PGC-1alpha contributes to neurodegeneration in Parkinson's disease. Cell 144, 689-702.
Liu S, Sawada T, Lee S, Yu W, Silverio G, Alapatt P, Millan I, Shen A, Saxton W, Kanao T et al. (2012) Parkinson's disease-associated kinase PINK1 regulates Miro protein level and axonal transport of mitochondria. PLoS Genet 8, e1002537.
Pickrell AM and Youle RJ (2015) The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease. Neuron 85, 257-273.
Ashrafi G and Schwarz TL (2013) The pathways of mitophagy for quality control and clearance of mitochondria. Cell Death Differ 20, 31-42.
Di Rita A, Peschiaroli A, D Acunzo P, Strobbe D, Hu Z, Gruber J, Nygaard M, Lambrughi M, Melino G, Papaleo E et al. (2018) HUWE1 E3 ligase promotes PINK1/PARKIN-independent mitophagy by regulating AMBRA1 activation via IKKalpha. Nat Commun 9, 3755.
Lemasters JJ (2014) Variants of mitochondrial autophagy: types 1 and 2 mitophagy and micromitophagy (Type 3). Redox Biol 2, 749-754.
Martinez-Vicente M (2017) Neuronal mitophagy in neurodegenerative diseases. Front Mol Neurosci 10, 64.
Palikaras K, Lionaki E and Tavernarakis N (2018) Mechanisms of mitophagy in cellular homeostasis, physiology and pathology. Nat Cell Biol 20, 1013-1022.
Yun J, Puri R, Yang H, Lizzio MA, Wu C, Sheng ZH and Guo M (2014) MUL1 acts in parallel to the PINK1/parkin pathway in regulating mitofusin and compensates for loss of PINK1/parkin. eLife. 3, e01958.
Zhuang N, Li L, Chen S and Wang T (2016) PINK1-dependent phosphorylation of PINK1 and Parkin is essential for mitochondrial quality control. Cell Death Dis 7, e2501.
Sun N, Yun J, Liu J, Malide D, Liu C, Rovira II, Holmstrom KM, Fergusson MM, Yoo YH, Combs CA et al. (2015) Measuring in vivo mitophagy. Mol Cell 60, 685-696.
Rana A, Rera M and Walker DW (2013) Parkin overexpression during aging reduces proteotoxicity, alters mitochondrial dynamics, and extends lifespan. Proc Natl Acad Sci USA 110, 8638-8643.
Cornelissen T, Vilain S, Vints K, Gounko N, Verstreken P and Vandenberghe W (2018) Deficiency of parkin and PINK1 impairs age-dependent mitophagy in Drosophila. eLife 7, e35878.
Palikaras K, Lionaki E and Tavernarakis N (2015) Coordination of mitophagy and mitochondrial biogenesis during ageing in C. elegans. Nature 521, 525-528.
Khalil B, El Fissi N, Aouane A, Cabirol-Pol MJ, Rival T and Lievens JC (2015) PINK1-induced mitophagy promotes neuroprotection in Huntington's disease. Cell Death Dis 6, e1617.
Hwang S, Disatnik MH and Mochly-Rosen D (2015) Impaired GAPDH-induced mitophagy contributes to the pathology of Huntington's disease. EMBO Mol Med 7, 1307-1326.
Guo X, Sun X, Hu D, Wang YJ, Fujioka H, Vyas R, Chakrapani S, Joshi AU, Luo Y, Mochly-Rosen D et al. (2016) VCP recruitment to mitochondria causes mitophagy impairment and neurodegeneration in models of Huntington's disease. Nat Commun 7, 12646.
Franco-Iborra S, Plaza-Zabala A, Montpeyo M, Sebastian D, Vila M and Martinez-Vicente M (2020) Mutant HTT (huntingtin) impairs mitophagy in a cellular model of Huntington disease. Autophagy 1-18.
Braak H and Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82, 239-259.
Mattson MP (2004) Pathways towards and away from Alzheimer's disease. Nature 430, 631-639.
Yao J, Irwin RW, Zhao L, Nilsen J, Hamilton RT and Brinton RD (2009) Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 106, 14670-14675.
Mairet-Coello G, Courchet J, Pieraut S, Courchet V, Maximov A and Polleux F (2013) The CAMKK2-AMPK kinase pathway mediates the synaptotoxic effects of Abeta oligomers through Tau phosphorylation. Neuron 78, 94-108.
Vossel KA, Zhang K, Brodbeck J, Daub AC, Sharma P, Finkbeiner S, Cui B and Mucke L (2010) Tau reduction prevents Abeta-induced defects in axonal transport. Science 330, 198.
Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T, Gerstein H, Yu GQ and Mucke L (2007) Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science 316, 750-754.
Fang EF, Hou Y, Palikaras K, Adriaanse BA, Kerr JS, Yang B, Lautrup S, Hasan-Olive MM, Caponio D, Dan X et al. (2019) Mitophagy inhibits amyloid-beta and tau pathology and reverses cognitive deficits in models of Alzheimer's disease. Nat Neurosci 22, 401-412.
Bose A and Beal MF (2016) Mitochondrial dysfunction in Parkinson's disease. J Neurochem 139 (Suppl 1), 216-231.
Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, Schrag AE and Lang AE (2017) Parkinson disease. Nat Rev Dis Primers. 3, 17013.
Hsieh CH, Shaltouki A, Gonzalez AE, Bettencourt da Cruz A, Burbulla LF, St Lawrence E, Schule B, Krainc D, Palmer TD and Wang X (2016) Functional impairment in miro degradation and mitophagy is a shared feature in familial and sporadic Parkinson's disease. Cell Stem Cell 19, 709-724.